Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-02-20 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a public notice published by Sanofi India Limited regarding the sale and transfer of certain flats, car parking spaces, and equity shares in a cooperative housing society. It includes legal language about claims, objections, and rights related to the property and shares, and is signed by advocates representing the purchasers. There is no indication of financial data, company financial performance, management discussion, or regulatory filings related to financial results or corporate governance. The document is a legal/public notice related to property and share transfer, not a financial report or corporate announcement such as AGM materials, earnings, or board changes. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is also not a regulatory filing in the sense of compliance or officer certifications. Given the nature of the document as a public legal notice about property and share transfer, the closest fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not neatly fit into other categories.
2024-02-20 English
Please find enclosed copies of the Notice to Shareholders of the Company published today, in newspapers, Business Standard and Sakal.
Regulatory Filings Classification · 95% confidence The document is a public notice published by Sanofi India Limited regarding the sale and transfer of flats and car parking spaces, including details about claims and objections related to the property. It is addressed to stock exchanges but does not contain financial statements, earnings data, management discussion, or regulatory certifications. The content is legal and transactional in nature, focusing on property transfer and public notice requirements. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it is not announcing a report release but a legal public notice. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2024-02-20 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the results of a postal ballot conducted by Sanofi India Limited. It includes voting results, percentages of votes in favor and against, and the appointment of a new director and whole-time director/Chief Financial Officer. The document references compliance with SEBI regulations and the Companies Act, and includes a scrutinizer's report on the voting process. The content is focused on the official results of shareholder voting on specific resolutions, not on the meeting materials, management discussion, or financial results. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a report publication notice, but the actual voting results report.
2024-02-14 English
Outcome of Postal Ballot along with Scrutinizer''s Report
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the results of a postal ballot conducted by Sanofi India Limited. It includes voting results for the appointment of a new director and whole-time director/Chief Financial Officer, with detailed vote counts and percentages. It also contains the Scrutinizer's report on the voting process, referencing compliance with the Companies Act, 2013 and SEBI regulations. The document is not a full annual report, earnings release, or management discussion but specifically reports the official voting results of shareholder resolutions. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is substantial and contains detailed voting data, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2024-02-14 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and provides details of shareholders and share certificate numbers. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. The content is an official regulatory announcement related to share certificates, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like share issue or capital change (SHA) or director dealings (DIRS). The document length is short and it is an announcement rather than a report itself.
2024-02-13 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and provides details of shareholders and share certificate numbers. There is no financial data, report, or presentation content. The document is an official regulatory announcement about share certificate issuance, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like share issue or capital change (SHA) because it concerns duplicate certificates, not new shares or capital changes.
2024-02-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.